Needle-Free Injection Systems Market To Reach $466 Million by 2030
Get more insights: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market
The needle-free injection systems market was sized at $151 million in 2021 and will grow at a rate of about 13% by the end of this decade, to generate $466 million by 2030. This is due to the global increasing diabetic population, generating high demand for self-injection instruments; snowballing prevalence of needlestick injuries; and the people fearing needles.
The needle-free injection systems market of North America has the largest demand of above 40%, in 2021, and it will lead the market in the future as well. This is a result of the incidence of advanced healthcare infra, increasing level of patient consciousness, surge in cases of chronic ailments, and high research and development expenditure on needle-free injection techniques.
Get more insights: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market
The needle-free injection systems market was sized at $151 million in 2021 and will grow at a rate of about 13% by the end of this decade, to generate $466 million by 2030. This is due to the global increasing diabetic population, generating high demand for self-injection instruments; snowballing prevalence of needlestick injuries; and the people fearing needles.
The needle-free injection systems market of North America has the largest demand of above 40%, in 2021, and it will lead the market in the future as well. This is a result of the incidence of advanced healthcare infra, increasing level of patient consciousness, surge in cases of chronic ailments, and high research and development expenditure on needle-free injection techniques.
Needle-Free Injection Systems Market To Reach $466 Million by 2030
Get more insights: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market
The needle-free injection systems market was sized at $151 million in 2021 and will grow at a rate of about 13% by the end of this decade, to generate $466 million by 2030. This is due to the global increasing diabetic population, generating high demand for self-injection instruments; snowballing prevalence of needlestick injuries; and the people fearing needles.
The needle-free injection systems market of North America has the largest demand of above 40%, in 2021, and it will lead the market in the future as well. This is a result of the incidence of advanced healthcare infra, increasing level of patient consciousness, surge in cases of chronic ailments, and high research and development expenditure on needle-free injection techniques.
0 Comments
0 Shares
970 Views